CytoMed Therapeutics Ltd
GDTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873093
In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding CytoMed Therapeutics Ltd changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 54 | +54 |
| Value | $0 | $165 | +$165 |
New holders (1)
Institutions that held CytoMed Therapeutics Ltd at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 54 | $165 | 0.00% |
Sold out (0)
Institutions that held CytoMed Therapeutics Ltd at the end of Q1 2023 and filed for Q2 2023 without it.
None.